- Home
- DNLI vs EXK Comparison
DNLI vs EXK Comparison
Compare DNLI & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | EXK |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.4B |
| IPO Year | 2017 | 2004 |
Fundamental Metrics
Financial Performance| Metric | DNLI | EXK |
|---|---|---|
| Price | $18.70 | $8.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $34.33 | $13.94 |
| AVG Volume (30 Days) | 1.2M | ★ 7.1M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $69.59 |
| Revenue Next Year | $408.85 | $17.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.58 | $3.23 |
| 52 Week High | $23.77 | $15.15 |
Technical Indicators
Market Signals| Indicator | DNLI | EXK |
|---|---|---|
| Relative Strength Index (RSI) | 41.36 | 39.97 |
| Support Level | $18.42 | $8.71 |
| Resistance Level | $19.17 | $10.40 |
| Average True Range (ATR) | 0.94 | 0.44 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 13.17 | 2.72 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.